S.Thepharm, an aesthetic products company that is a subsidiary of Kosdaq-listed S.Biomedics, said Monday that three of its hyaluronic acid fillers, Qtfill Signature, have received product licenses in Vietnam.Qtfill Signature consists of fillers used to improve facial wrinkles in adults through physi
The supply shortage of AstraZeneca Korea’s migraine treatment Zomig (zolmitriptan) Tab. has occurred again.According to the Ministry of Food and Drug Safety (MFDS), AstraZeneca reported a shortage of Zomig 2.5mg on Thursday. Zomig is a selective 5-HT receptor agonist and is licensed in Korea for the
Pharmgen Science said Friday that it has received approval from the Ministry of Food and Drug Safety (MFDS) for Pharmgen Covid/Flu A&B Antigen Combo, a kit for the simultaneous diagnosis of Covid-19 and influenza A and B viruses.The combo kit is a diagnostic device that detects covid-19 and influenz
ViGenCell said Thursday that a study demonstrating the world's first direct therapeutic effect on atopic dermatitis using cord blood-derived myeloid suppressor (CBMS) cells has been published in an SCI-ranked journal.The study, "Skin Repair and Immunoregulatory Effects of Myeloid Suppressor Cells fr
Daiichi Sankyo and AstraZeneca Korea's new antibody-drug conjugate (ADC) drug Enhertu 100 mg (trastuzumab deruxtecan) has been rejected by the Pharmaceutical Reimbursement Evaluation Committee.The Health Insurance Review and Assessment Service (HIRA) held this year’s first Pharmaceutical Reimburseme
Celltrion said Friday that its biosimilar products for autoimmune diseases are continuing to make an impact, winning bids in key European countries.First, Celltrion said that Yuflyma won state bids for adalimumab in Friuli-Venezia Giulia (FVG) and Sicilia, Italy, securing to provide Yuflyma for four
Ono Pharmaceutical Korea said Thursday that Braftovi (encorafenib), a targeted therapy for BRAF V600E-mutated metastatic colorectal cancer, has been approved for health insurance coverage effective Jan. 1.The reimbursement will be available in combination with cetuximab for patients with metastatic
LG Chem said Thursday that it will co-market Kyowa Kirin’s Nephoxil (ferric citrate hydrate), a hyperphosphatemia drug, for patients with chronic kidney disease undergoing hemodialysis in Korea. Hyperphosphatemia is a disorder of electrolyte metabolism caused by abnormal kidney function that can lea
Ahead of the patent expiration of anti-PD-1 inhibitor Keytruda (pembrolizumab), MSD (Merck & Co in the U.S.) is looking to secure new growth engines by developing Keytruda combination therapy and antibody-drug conjugate (ADC) pipeline.Yujin Investment & Securities analyzed MSD's stock price and pipe
Dong-A ST signed a memorandum of understanding with Eleven Therapeutics to develop RNA-based gene therapy on the sidelines of the J.P. Morgan Healthcare Conference on Tuesday (local time). The JPMHC 2024 is held in San Francisco, Calif., from Monday to Thursday.The two companies will collaborate on
Boryung said Wednesday that it has signed a sales agreement with Baxter Korea to sell inhalation anesthesia Suprane Solution and blood substitute Plasma Lyte 148 Inj 1,000ml in the domestic market.Suprane (desflurane), the original drug developed by Baxter, is a leading inhalation anesthetic used to
Ildong Pharmaceutical said Wednesday that it has signed an eye drop co-promotion agreement with Hanlim Pharm to enter the OTC (over-the-counter) market in the ophthalmology sector.The items to be co-promoted are three brands of over-the-counter eye drops -- Nazorin, Numaren, and Eyefeel -- which wil
Hyundai Pharm said Wednesday it has received approval from the Ministry of Food and Drug Safety (MFDS) for Niserin Tab 30mg (nicergoline), a brain function enhancer.Nicergoline inhibits alpha-1 adrenergic receptors, resulting in peripheral vasodilation to increase blood circulation in the brain.Nice
SK chemicals said Wednesday that they have launched Nose-R Soft Cap (fexofenadine), a third-generation antihistamine-based drug for allergic rhinitis.Nose-R is available at pharmacies without a prescription and is effective in relieving symptoms of allergic rhinitis caused by pollen and house dust,
Samsung C&T and its subsidiaries Samsung BioLogics and Samsung Bioepis said Tuesday that they have signed a memorandum of understanding for strategic cooperation with Flagship Pioneering in the United States through the Life Science Fund No. 2 (SVIC No. 64 New Technology Investment Fund) established
Celltrion said Wednesday that it has applied to the U.S. Food and Drug Administration (FDA) for securing interchangeability between CT-P17 (adalimumab) and its original drug, AbbVie’s Humira, for treating autoimmune diseases.Celltrion's application for the interchangeability of CT-P17 (Yuflyma in br
On Friday, Samsung Pharm said it has submitted an application to the Ministry of Food and Drug Safety (MFDS) seeking approval to modify the investigational new drug (IND) plan for the phase 3 clinical trial of its Alzheimer's treatment, GV1001.The amended protocol is designed to test the superiority
Celltrion said Monday that it has begun canceling approximately 2.3 million treasury shares to enhance shareholder value.Following the launch of the unified Celltrion, the company aims to bolster its global competitiveness, maintaining shareholder-friendly policies such as outstanding share repurcha
Huons, a Korean healthcare company listed on Kosdaq, said Monday it has received IND approval from the Ministry of Food and Drug Safety for HUC1-394, a treatment for dry eye disease, to conduct a phase 1 clinical trial. HUC1-394 is a peptide-based eye drop for dry eyes. In 2020, Huons licensed-in th
AstraZeneca Korea said that the Ministry of Food and Drug Safety (MFDS) approved Ultomiris (ingredient: ravulizumab) as an adjunct therapy for adults with antibody-positive acetylcholine receptor (AChR) generalized myasthenia gravis (gMG) on Thursday.Ultomiris had been approved for the treatment of